{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:13:51Z","timestamp":1790496831460,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.arcmed.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T21:32:50Z","timestamp":1551821570000},"page":"423-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["New Advances of Heparanase and Heparanase-2 in Human Diseases"],"prefix":"10.1016","volume":"49","author":[{"given":"Hao","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2019.02.004_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/1389557516666161101143643","article-title":"The functions of heparanase in human diseases","volume":"17","author":"Jin","year":"2017","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.arcmed.2019.02.004_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.arcmed.2019.02.004_bib3","first-page":"1145","article-title":"Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition","volume":"32","author":"Masola","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arcmed.2019.02.004_bib4","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0959-8049(17)30338-6","article-title":"611A - The close relationship between heparanase and epithelial mesenchymal transition related fibrosis in gastric signet-ring cell adenocarcinoma","volume":"72","author":"Shah","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.arcmed.2019.02.004_bib5","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/S0049-3848(07)70139-1","article-title":"Heparanase, heparin and the coagulation system in cancer progression","volume":"120","author":"Vlodavsky","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2019.02.004_bib6","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/jth.13707","article-title":"Involvement of heparanase procoagulant domain in bleeding and wound healing","volume":"15","author":"Crispel","year":"2017","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.arcmed.2019.02.004_bib7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/eurheartj\/ehx493.P5425","article-title":"P5425Relationship between heparanase levels and prosthetic valve thrombosis: clinical implications","volume":"38","author":"Bayam","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.arcmed.2019.02.004_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/ejh.12997","article-title":"Heparanase level and procoagulant activity are reduced in severe sepsis","volume":"100","author":"Matan","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.arcmed.2019.02.004_bib9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/cbin.10748","article-title":"Heparanase 1 involvement in prostate physiopathology","volume":"41","author":"Barbosa","year":"2017","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.arcmed.2019.02.004_bib10","doi-asserted-by":"crossref","first-page":"19403","DOI":"10.18632\/oncotarget.14292","article-title":"Heparanase augments insulin receptor signaling in breast carcinoma","volume":"8","author":"Goldberg","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arcmed.2019.02.004_bib11","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.18632\/oncotarget.23560","article-title":"Prognostic significance of heparanase expression in primary and metastatic breast carcinoma","volume":"9","author":"Vornicova","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arcmed.2019.02.004_bib12","doi-asserted-by":"crossref","first-page":"43521","DOI":"10.18632\/oncotarget.16575","article-title":"Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arcmed.2019.02.004_bib13","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1158\/1535-7163.MCT-16-0900","article-title":"Inhibition of heparanase in pediatric brain tumor cells attenuates their proliferation, invasive capacity, and in\u00a0vivo tumor growth","volume":"16","author":"Spyrou","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.arcmed.2019.02.004_bib14","first-page":"1705","article-title":"Involvement of heparanase in the pathogenesis of mesothelioma: basic aspects and clinical applications","volume":"16","author":"Barash","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.arcmed.2019.02.004_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dna.2017.3990","article-title":"Heparanase is a critica et\u00a0al. regulator of mitotic spindles required for maintaining chromosome stability","volume":"37","author":"Yang","year":"2018","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.arcmed.2019.02.004_bib16","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/aps.2017.189","article-title":"CTC clusters induced by heparanase enhance breast cancer metastasis","volume":"39","author":"Wei","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.arcmed.2019.02.004_bib17","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI92958","article-title":"NK cell heparanase controls tumor invasion and immune surveillance","volume":"127","author":"Putz","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2019.02.004_bib18","first-page":"129","article-title":"Role of the beta-D-endoglucuronidase heparanase in septic cardiomyopathy","volume":"47","author":"Martin","year":"2017","journal-title":"Shock"},{"key":"10.1016\/j.arcmed.2019.02.004_bib19","first-page":"1809","article-title":"Interleukin-17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer","volume":"53","author":"Lv","year":"2018","journal-title":"Int J Oncol"},{"key":"10.1016\/j.arcmed.2019.02.004_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/3502386","article-title":"Heparanase overexpresses in keratoconic cornea and tears depending on the pathologic grade","volume":"2017","author":"Beatriz","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.arcmed.2019.02.004_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0912-8","article-title":"Heparanase promotes neuroinflammatory response during subarachnoid hemorrhage in rats","volume":"14","author":"Changyaleket","year":"2017","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.arcmed.2019.02.004_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.thromres.2009.11.026","article-title":"Involvement of heparanase in early pregnancy losses","volume":"125","author":"Nadir","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2019.02.004_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1582-4934.2007.00039.x","article-title":"Mammalian heparanase: what is the message?","volume":"11","author":"Vreys","year":"2007","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.arcmed.2019.02.004_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/molehr\/8.6.566","article-title":"Localization of heparanase in normal and pathological human placenta","volume":"8","author":"Haimov-Kochman","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.arcmed.2019.02.004_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2014.07.023","article-title":"Evaluation of glycosaminoglycans and heparanase in placentas of women with preeclampsia","volume":"437","author":"Eduardo","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arcmed.2019.02.004_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000338271","article-title":"Renal evaluation in women with preeclampsia","volume":"2","author":"Facca","year":"2012","journal-title":"Nephron Extra"},{"key":"10.1016\/j.arcmed.2019.02.004_bib27","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3109\/14767058.2014.962506","article-title":"The expression of heparanase in normal and preeclamptic placentas","volume":"28","author":"Shimon","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.arcmed.2019.02.004_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0049-3848(10)70018-9","article-title":"Heparanase procoagulant effects and inhibition by heparins","volume":"125","author":"Nadir","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2019.02.004_bib29","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/CIRCULATIONAHA.111.046821","article-title":"Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy","volume":"124","author":"Rosenberg","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2019.02.004_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.placenta.2017.06.006","article-title":"Bovine placentomal heparanase and syndecan expression is related to placental maturation","volume":"57","author":"Hambruch","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.arcmed.2019.02.004_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.12891\/ceog3796.2018","article-title":"Expression of heparanase in the spontaneously aborted human chorionic villus","volume":"45","author":"Mu","year":"2018","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.arcmed.2019.02.004_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00005-016-0396-8","article-title":"Increased granulocyte heparanase activity in neutrophils from patients with lupus nephritis and idiopathic membranous nephropathy","volume":"65","author":"Szymczak","year":"2017","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1016\/j.arcmed.2019.02.004_bib33","doi-asserted-by":"crossref","first-page":"34191","DOI":"10.18632\/oncotarget.16573","article-title":"Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545","volume":"8","author":"Abassi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arcmed.2019.02.004_bib34","doi-asserted-by":"crossref","first-page":"i365","DOI":"10.1093\/ndt\/gfy104.SP059","article-title":"SP059 HEPARANASE a key regulator of the chronic profibrotic kidney damage following ischemia\/reperfusion injury","volume":"33","author":"Valentina","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arcmed.2019.02.004_bib35","first-page":"1","article-title":"Emerging roles of heparanase in viral pathogenesis","volume":"6","author":"Neel","year":"2017","journal-title":"Pathogens"},{"key":"10.1016\/j.arcmed.2019.02.004_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.celrep.2017.06.041","article-title":"Viral activation of heparanase drives pathogenesis of herpes simplex virus-1","volume":"20","author":"Agelidis","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.arcmed.2019.02.004_bib37","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1038\/s41598-017-14946-0","article-title":"Heparanase and macrophage interplay in the onset of liver fibrosis","volume":"7","author":"Secchi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2019.02.004_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.matbio.2016.11.007","article-title":"Heparanase confers a growth advantage to differentiating murine embryonic stem cells, and enhances oligodendrocyte formation","volume":"62","author":"Garcia","year":"2017","journal-title":"Matrix Biol"},{"key":"10.1016\/j.arcmed.2019.02.004_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JAD-161298","article-title":"Upregulated expression of heparanase and heparanase 2 in the brains of Alzheimer\u2019s disease","volume":"58","author":"Garcia","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.arcmed.2019.02.004_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jneuroim.2017.07.001","article-title":"Heparanase: potential roles in multiple sclerosis","volume":"310","author":"Changyaleket","year":"2017","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.arcmed.2019.02.004_bib41","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1038\/s41598-018-23070-6","article-title":"Heparanase attenuates axon degeneration following sciatic nerve transection","volume":"8","author":"Whitehead","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2019.02.004_bib42","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1016\/j.bmcl.2017.08.013","article-title":"Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors","volume":"27","author":"Rondanin","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.arcmed.2019.02.004_bib43","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.15252\/embr.201643581","article-title":"CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells","volume":"18","author":"Li","year":"2017","journal-title":"EMBO Rep"},{"key":"10.1016\/j.arcmed.2019.02.004_bib44","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1158\/1078-0432.CCR-17-0242","article-title":"Aspirin inhibits cancer metastasis and angiogenesis via targeting heparanase","volume":"23","author":"Dai","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2019.02.004_bib45","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1039\/C7CC04156J","article-title":"Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity","volume":"53","author":"Loka","year":"2017","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.arcmed.2019.02.004_bib46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/md15050134","article-title":"Assessment of heparanase-mediated angiogenesis using microvascular endothelial cells: identification of \u03bb-carrageenan derivative as a potent anti angiogenic agent","volume":"15","author":"Poupard","year":"2017","journal-title":"Mar Drugs"},{"key":"10.1016\/j.arcmed.2019.02.004_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.vetmic.2017.01.033","article-title":"Pyrithione inhibits porcine reproductive and respiratory syndrome virus replication through interfering with NF-B-K and heparanase","volume":"201","author":"Guo","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.arcmed.2019.02.004_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3214-8","article-title":"Identification of novel class of triazolo-thiadiazoles as potent inhibitors of human heparanase and their anticancer activity","volume":"17","author":"Baburajeev","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arcmed.2019.02.004_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/or.2016.5269","article-title":"Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2\/-9 and heparanase in MDA-MB-231 cells","volume":"37","author":"Lou","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.arcmed.2019.02.004_bib50","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hon.2466","article-title":"Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat","volume":"36","author":"Rossini","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.arcmed.2019.02.004_bib51","doi-asserted-by":"crossref","first-page":"1707289","DOI":"10.1002\/adfm.201707289","article-title":"Tumor cells-selective bionic nanodevice exploiting heparanase combats metastatic breast cancer","volume":"28","author":"Lang","year":"2018","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.arcmed.2019.02.004_bib52","doi-asserted-by":"crossref","first-page":"28010","DOI":"10.1074\/jbc.M110.116384","article-title":"Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity","volume":"285","author":"Levy-Adam","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2019.02.004_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tibs.2017.10.007","article-title":"Opposing functions of heparanase-1 and heparanase-2 in cancer progression","volume":"43","author":"Vlodavsky","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.arcmed.2019.02.004_bib54","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.canep.2013.09.012","article-title":"High expression of heparanase-2 is an independent prognostic parameter for favorable survival in\u00a0gastric cancer patients","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.arcmed.2019.02.004_bib55","first-page":"73","article-title":"Heparanase and heparanase 2 display differently deregulation in neuroendocrine tumors, depending on their differentiation grade","volume":"31","author":"Garc\u00eda","year":"2016","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.arcmed.2019.02.004_bib56","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1093\/hmg\/ddu147","article-title":"Heparanase 2, mutated in urofacial syndrome, mediates peripheral neural development in Xenopus","volume":"23","author":"Roberts","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.arcmed.2019.02.004_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1410-y","article-title":"Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression","volume":"15","author":"Fu","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arcmed.2019.02.004_bib58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/IGC.0000000000000329","article-title":"Immunohistochemical expression of heparanases 1 and 2 in benign tissue and in invasive neoplasia of the endometrium: a case-control study","volume":"25","author":"Signorini","year":"2015","journal-title":"Int J Gynecol Cancer"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844091830763X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844091830763X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:47:16Z","timestamp":1759261636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018844091830763X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S018844091830763X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2019.02.004","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Advances of Heparanase and Heparanase-2 in Human Diseases","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 IMSS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}